Kurtoglu Metin
Chief Technology Officer | Chief Operating Officer
1 company
Insider Signal Score
80
ExcellentTrades Analyzed
10
12M Win Rate
100.0%
Avg 3M Return
+4.9%
Avg 12M Return
+59.9%
Kurtoglu Metin is a Chief Technology Officer at Cartesian Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $614K based on current market prices.
Holdings by Company
RNACJan 6, 2025
Current Shares62.3K
Value$614.5K
Net Activity-139,596
Bought: 0Sold: 139.6K
Transaction History
Showing 4 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | RNAC Cartesian Therapeutics, Inc. | Chief Technology Officer | Sell | 4,875 | $16.78 | $81,790.38 | -3.7% | -42.7% | -60.1% | |
| Dec 10, 2024 | RNAC Cartesian Therapeutics, Inc. | Chief Technology Officer | Sale+OE | 13,664 | $25.26 | $345,133.86 | -8.0% | -21.5% | -65.6% | |
| Nov 21, 2024 | RNAC Cartesian Therapeutics, Inc. | Chief Technology Officer | Sale+OE | 38,689 | $16.78 | $649,029.56 | -15.9% | +16.4% | -56.4% | |
| Nov 18, 2024 | RNAC Cartesian Therapeutics, Inc. | Chief Technology Officer | Sale+OE | 82,368 | $17.46 | $1,438,037.68 | -22.9% | +5.1% | -59.0% |